| First Author | Araki O | Year | 2023 |
| Journal | Oncogene | Volume | 42 |
| Issue | 26 | Pages | 2139-2152 |
| PubMed ID | 37198398 | Mgi Jnum | J:337526 |
| Mgi Id | MGI:7494435 | Doi | 10.1038/s41388-023-02716-4 |
| Citation | Araki O, et al. (2023) Brg1 controls stemness and metastasis of pancreatic cancer through regulating hypoxia pathway. Oncogene 42(26):2139-2152 |
| abstractText | Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease. We previously reported that chromatin remodeler Brg1 is essential for acinar cell-derived PDAC formation in mice. However, the functional role of Brg1 in established PDAC and its metastasis remains unknown. Here, we investigated the importance of Brg1 for established PDAC by using a mouse model with a dual recombinase system. We discovered that Brg1 was a critical player for the cell survival and growth of spontaneously developed PDAC in mice. In addition, Brg1 was essential for metastasis of PDAC cells by inhibiting apoptosis in splenic injection and peritoneal dissemination models. Moreover, cancer stem-like property was compromised in PDAC cells by Brg1 ablation. Mechanistically, the hypoxia pathway was downregulated in Brg1-deleted mouse PDAC and BRG1-low human PDAC. Brg1 was essential for HIF-1alpha to bind to its target genes to augment the hypoxia pathway, which was important for PDAC cells to maintain their stem-like properties and to metastasize to the liver. Human PDAC cells with high BRG1 expression were more susceptible to BRG1 suppression. In conclusion, Brg1 plays a critical role for cell survival, stem-like property and metastasis of PDAC through the regulation of hypoxia pathway, and thus could be a novel therapeutic target for PDAC. |
